BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 9258734)

  • 1. Technetium 99m tetrofosmin parathyroid imaging. Results with double-phase study and SPECT in primary and secondary hyperparathyroidism.
    Gallowitsch HJ; Mikosch P; Kresnik E; Gomez I; Lind P
    Invest Radiol; 1997 Aug; 32(8):459-65. PubMed ID: 9258734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between 99mTc-tetrofosmin/pertechnetate subtraction scintigraphy and 99mTc-tetrofosmin SPECT for preoperative localization of parathyroid adenoma in an endemic goiter area.
    Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Lind P
    Invest Radiol; 2000 Aug; 35(8):453-9. PubMed ID: 10946972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Technetium-99m tetrofosmin parathyroid imaging in patients with primary hyperparathyroidism.
    Hiromatsu Y; Ishibashi M; Nishida H; Okuda S; Miyake I
    Intern Med; 2000 Feb; 39(2):101-6. PubMed ID: 10732824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 99mTc-tetrofosmin or 99mTc-sestamibi for double-phase parathyroid scintigraphy?
    Fröberg AC; Valkema R; Bonjer HJ; Krenning EP
    Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):193-6. PubMed ID: 12552335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of parathyroid glands using technetium-99m-tetrofosmin imaging.
    Ishibashi M; Nishida H; Strauss HW; Kojima K; Fujito H; Watanabe J; Hiromatsu Y; Hayabuchi N
    J Nucl Med; 1997 May; 38(5):706-11. PubMed ID: 9170432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Technetium-99m-tetrofosmin for parathyroid scintigraphy: a comparison with sestamibi.
    Fjeld JG; Erichsen K; Pfeffer PF; Clausen OP; Rootwelt K
    J Nucl Med; 1997 Jun; 38(6):831-4. PubMed ID: 9189124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The usefulness of neck pinhole SPECT as a complementary tool to planar scintigraphy in primary and secondary hyperparathyroidism.
    Spanu A; Falchi A; Manca A; Marongiu P; Cossu A; Pisu N; Chessa F; Nuvoli S; Madeddu G
    J Nucl Med; 2004 Jan; 45(1):40-8. PubMed ID: 14734671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-phase Tc-99m sestamibi scintigraphy in the preoperative location of lesions causing hyperparathyroidism.
    Blanco I; Carril JM; Banzo I; Quirce R; Gutierrez C; Uriarte I; Montero A; Vallina NK
    Clin Nucl Med; 1998 May; 23(5):291-7. PubMed ID: 9596153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The role of scintigraphy with dual tracer and potassium perchlorate (99mTcO4 & KClO4/ MIBI) in primary hyperparathyroidism].
    Rubello D; Saladini G; Casara D
    Minerva Endocrinol; 2001 Mar; 26(1):13-21. PubMed ID: 11323563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of technetium-99m-MIBI, technetium-99m-tetrofosmin, ultrasound and MRI for localization of abnormal parathyroid glands.
    Ishibashi M; Nishida H; Hiromatsu Y; Kojima K; Tabuchi E; Hayabuchi N
    J Nucl Med; 1998 Feb; 39(2):320-4. PubMed ID: 9476944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical utility of ultrasound and 99mTc sestamibi SPECT/CT for preoperative localization of parathyroid adenoma in patients with primary hyperparathyroidism.
    Patel CN; Salahudeen HM; Lansdown M; Scarsbrook AF
    Clin Radiol; 2010 Apr; 65(4):278-87. PubMed ID: 20338394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasonography for preoperative localization of enlarged parathyroid glands in primary hyperparathyroidism: comparison with (99m)technetium sestamibi scintigraphy.
    Haber RS; Kim CK; Inabnet WB
    Clin Endocrinol (Oxf); 2002 Aug; 57(2):241-9. PubMed ID: 12153604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of parathyroid imaging with technetium-99m-pertechnetate/sestamibi subtraction, double-phase technetium-99m-sestamibi and technetium-99m-sestamibi SPECT.
    Chen CC; Holder LE; Scovill WA; Tehan AM; Gann DS
    J Nucl Med; 1997 Jun; 38(6):834-9. PubMed ID: 9189125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The value of 99mTc-sestamibi SPECT/CT over conventional SPECT in the evaluation of parathyroid adenomas or hyperplasia.
    Gayed IW; Kim EE; Broussard WF; Evans D; Lee J; Broemeling LD; Ochoa BB; Moxley DM; Erwin WD; Podoloff DA
    J Nucl Med; 2005 Feb; 46(2):248-52. PubMed ID: 15695783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of a gamma probe for intraoperative localization of parathyroid adenomas with Tc-99m-tetrofosmin and Tc-99m-sestamibi].
    Gallowitsch HJ; Fellinger J; Kresnik E; Mikosch P; Pipam W; Unterweger OF; Lind P
    Acta Med Austriaca; 1997; 24(2):73-8. PubMed ID: 9273810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical role of 99mTcO4/MIBI scan, ultrasound and intra-operative gamma probe in the performance of unilateral and minimally invasive surgery in primary hyperparathyroidism.
    Casara D; Rubello D; Pelizzo MR; Shapiro B
    Eur J Nucl Med; 2001 Sep; 28(9):1351-9. PubMed ID: 11585294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Technetium-99m-tetrofosmin for parathyroid scintigraphy: comparison to thallium-technetium scanning.
    Apostolopoulos DJ; Houstoulaki E; Giannakenas C; Alexandrides T; Spiliotis J; Nikiforidis G; Vlachojannis JG; Vassilakos PJ
    J Nucl Med; 1998 Aug; 39(8):1433-41. PubMed ID: 9708523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Use of 99mTc-tetrofosmin scintigraphy in the diagnosis of patients with hyperparathyroidism].
    Vallejos V; Martín-Comín J; Mora J; González MT; Rafecas A; Muñoz A; Fernández A; Castell M; Ricard Y; Ramos M
    Rev Esp Med Nucl; 1998; 17(2):94-101. PubMed ID: 9611279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of SPECT/CT, SPECT, and planar imaging with single- and dual-phase (99m)Tc-sestamibi parathyroid scintigraphy.
    Lavely WC; Goetze S; Friedman KP; Leal JP; Zhang Z; Garret-Mayer E; Dackiw AP; Tufano RP; Zeiger MA; Ziessman HA
    J Nucl Med; 2007 Jul; 48(7):1084-9. PubMed ID: 17574983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative ⁹⁹mTc-sestamibi scintigraphy in patients with primary hyperparathyroidism and concomitant nodular goiter: comparison of SPECT-CT, SPECT, and planar imaging.
    Shafiei B; Hoseinzadeh S; Fotouhi F; Malek H; Azizi F; Jahed A; Hadaegh F; Salehian M; Parsa H; Javadi H; Assadi M
    Nucl Med Commun; 2012 Oct; 33(10):1070-6. PubMed ID: 22825041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.